Home > Products > HER3 & IGF1R
> Recombinant Anti-HER3 x Anti-IGF1R Bispecific Antibody (scIgG)
Recombinant Anti-HER3 x Anti-IGF1R Bispecific Antibody (scIgG) (CAT#: SCIGG-169)
Recombinant Anti-HER3 x Anti-IGF1R Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-HER3 and anti-IGF1R IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can bind and inactivate two receptors simultaneously. It is designed for the research of Pancreatic cancer; Hepatocellular carcinoma (HCC) therapy.
There are currently no customer reviews or questions for Recombinant Anti-HER3 x Anti-IGF1R Bispecific Antibody (scIgG) (SCIGG-169). Click the button below to contact us or submit your feedback about this product.